# Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming

> **NIH NIH UG1** · MONTANA CANCER CONSORTIUM · 2020 · $881,991

## Abstract

PROJECT SUMMARY
The Montana Cancer Consortium (MCC) is an independent, nonprofit organization whose mission is to bring
state-of-the-art cancer care to Montana, Idaho, and Wyoming through National Cancer Institute (NCI)
sponsored clinical research. MCC coordinates, supports and improves the activities of physicians and other
cancer care professionals, cancer centers and hospitals across the service area to maximize patient access to
the highest levels of cancer care with a focus on access to clinical trials. In addition, MCC helps to design and
influence cancer care delivery research through continued participation that informs and speeds validated care
innovations into clinical practice. The region has been characterized as `mega-rural' with limited access to care
due to the vastness of the geography, lack of university-based treatment and research facilities, and lack of
primary care providers. Montana, Idaho and Wyoming are home to seven, five, and one American Indian
Reservations respectively, where issues of poverty, distance, and cultural taboos surrounding cancer care
discussion and treatment create unique disparities to prevention, early diagnosis, treatment and survivorship of
cancer. The overall goal of MCC is to increase access to clinical trials in the service area while improving the
delivery of cancer care through research. This is accomplished through inclusiveness of membership,
communication, education, a commitment to quality, and participation in national clinical trial initiatives. The
MCC NCORP Community Site consists of 10 primary affiliate sites and nine sub-affiliates that collectively serve
nearly two million residents in an area covering over 200,000 square miles. Membership includes 60 oncology
investigators representing all cancer care specialty areas. MCC is a member in good standing with the four
adult research bases, and is poised to provide and support expanded access to state-of-the-art cancer
treatment, control, prevention, screening, surveillance and care delivery through NCI-sponsored clinical trials.
Strong leadership, an involved network of member physicians and dedicated affiliate sites strengthens MCC as
an NCORP Community Site.

## Key facts

- **NIH application ID:** 9993364
- **Project number:** 5UG1CA189872-07
- **Recipient organization:** MONTANA CANCER CONSORTIUM
- **Principal Investigator:** Justin Neal Bottsford-Miller
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $881,991
- **Award type:** 5
- **Project period:** 2014-08-09 → 2025-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9993364

## Citation

> US National Institutes of Health, RePORTER application 9993364, Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming (5UG1CA189872-07). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9993364. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*